1-(9H-Carbazol-4-Yloxy)-3-(1-Fluoropropan-2-Ylamino)Propan-2-Ol

CAS: 157989-11-2

Ref. 3D-FC97269

Información del producto

• Nombre: 1-(9H-Carbazol-4-Yloxy)-3-(1-Fluoropropan-2-Ylamino)Propan-2-Ol
• Sinónimos: (18F)-Fluorocarazolol, (S-(R*,S*))-1-(9H-Carbazol-4-yloxy)-3-((2-(fluoro-18F)-1-methylethyl)amino)-2-propanol, 1-(9H-Carbazol-4-yloxy)-3-((1-(fluoromethyl)ethyl)amino)-2-propanol, Ccris 8435, 2-Propanol, 1-(9H-carbazol-4-yloxy)-3-((2-(fluoro-18F)-1-methylethyl)amino)-, (S-(R*,S*))-, 1-(9H-carbazol-4-yloxy)-3-[(1-fluoropropan-2-yl)amino]propan-2-ol

Descripción

1-(9H-Carbazol-4-Yloxy)-3-(1-Fluoropropan-2-Ylamino)Propan-2-Ol is a positron emission tomography (PET) imaging agent that binds to β adrenergic receptors. This drug has been shown in vitro to bind to β adrenergic receptors and, as a result, can be used for the diagnosis of cardiac diseases. 1-(9H-Carbazol-4-Yloxy)-3-(1-Fluoropropan-2-Ylamino)Propan-2-Ol is also used in vivo studies for the detection of efflux pump activity and neurotransmission. It is an effective dose of 1.5 mCi with a range of 0.05 - 2.0 mCi per person. The radionuclide used in this drug is 18F, which emits positrons that are detected by PET imaging devices during

• Marca: Biosynth

Propiedades químicas

• Peso molecular: 316.37 g/mol
• Fórmula: C₁₈H₂₁FN₂O₂
• Pureza: Min. 95%
• InChI: InChI=1S/C18H21FN2O2/c1-12(9-19)20-10-13(22)11-23-17-8-4-7-16-18(17)14-5-2-3-6-15(14)21-16/h2-8,12-13,20-22H,9-11H2,1H3
• Clave InChI: InChIKey=QHLGXPUIUKSADT-UHFFFAOYSA-N
• SMILES: CC(CF)NCC(O)COc1cccc2[nH]c3ccccc3c12